Pharmaceuticals
Sun-Ranbaxy merger: competition panel demands more details
28 Aug 2014
This is probably the first instance where the fair trade watchdog has ordered a public scrutiny of a proposed merger and acquisition deal to ensure compliance to fair trade regulation
Roche to buy InterMune for $8.3 bn
25 Aug 2014
The purchase of InterMune, a developer of a drug for pulmonary fibrosis, would add $1 billion in global sales for Roche by 2019
Ranbaxy faces fresh US penalty of Rs242 cr over Toansa-made API
22 Aug 2014
This is the second such penalty for the company, which paid $500 million to the US department of justice (DoJ) in May 201
.webp)
.webp)
